Your browser doesn't support javascript.
loading
High Prevalence of Multidrug-Resistant Organism Colonization in 28 Nursing Homes: An "Iceberg Effect".
McKinnell, James A; Miller, Loren G; Singh, Raveena D; Gussin, Gabrielle; Kleinman, Ken; Mendez, Job; Laurner, Bryn; Catuna, Tabitha D; Heim, Lauren; Saavedra, Raheeb; Felix, James; Torres, Crystal; Chang, Justin; Estevez, Marlene; Mendez, Joanna; Tchakalian, Gregory; Bloomfield, Leah; Ceja, Sandra; Franco, Ryan; Miner, Aaron; Hurtado, Aura; Hean, Ratharo; Varasteh, Alex; Robinson, Philip A; Park, Steven; Tam, Steven; Tjoa, Thomas; He, Jiayi; Agrawal, Shalini; Yamaguchi, Stacey; Custodio, Harold; Nguyen, Jenny; Bittencourt, Cassiana E; Evans, Kaye D; Mor, Vincent; McConeghy, Kevin; Weinstein, Robert A; Hayden, Mary K; Stone, Nimalie D; Steinberg, Karl; Beecham, Nancy; Montgomery, Jocelyn; DeAnn, Walters; Peterson, Ellena M; Huang, Susan S.
Affiliation
  • McKinnell JA; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA; Los Angeles County Department of Public Health, Healthcare Outreach Unit, Los Angeles, CA, USA; Expert Stewardship, Newport, CA, USA. Electronic address: Dr.Mc
  • Miller LG; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Singh RD; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Gussin G; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Kleinman K; University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst, MA, USA.
  • Mendez J; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Laurner B; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Catuna TD; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Heim L; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Saavedra R; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Felix J; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Torres C; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Chang J; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Estevez M; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Mendez J; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Tchakalian G; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Bloomfield L; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Ceja S; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Franco R; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Miner A; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Hurtado A; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Hean R; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Varasteh A; Department of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Robinson PA; Expert Stewardship, Newport, CA, USA; Hoag Hospital, Newport, CA, USA.
  • Park S; Department of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
  • Tam S; Division of Geriatrics, Department of Medicine, University of California Irvine, Orange, CA, USA.
  • Tjoa T; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • He J; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Agrawal S; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Yamaguchi S; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Custodio H; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Nguyen J; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Bittencourt CE; Department of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
  • Evans KD; Department of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
  • Mor V; Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI, USA; Center of Innovation in Long-Term Services and Supports, Veterans Affairs Medical Center, Providence VA Medical Center, Providence, RI, USA; Center for Long-Term Care Quality and Innova
  • McConeghy K; Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI, USA; Center of Innovation in Long-Term Services and Supports, Veterans Affairs Medical Center, Providence VA Medical Center, Providence, RI, USA; Center for Long-Term Care Quality and Innova
  • Weinstein RA; Cook County Health and Hospitals System, Chicago, IL, USA; Department of Medicine, Rush University Medical Center, Chicago, IL, USA.
  • Hayden MK; Department of Medicine, Rush University Medical Center, Chicago, IL, USA.
  • Stone ND; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Steinberg K; California Association of Long Term Care Medicine, Santa Clarita, CA, USA.
  • Beecham N; The National Association of Directors of Nursing Administration in Long Term Care, Springdale, OH, USA.
  • Montgomery J; California Association of Health Facilities, Sacramento, CA, USA.
  • DeAnn W; California Association of Health Facilities, Sacramento, CA, USA.
  • Peterson EM; Department of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
  • Huang SS; Division of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Medicine, Health Policy Research Institute, University of California Irvine School of Medicine, Irvine, CA, USA.
J Am Med Dir Assoc ; 21(12): 1937-1943.e2, 2020 12.
Article in En | MEDLINE | ID: mdl-32553489
ABSTRACT

OBJECTIVE:

Determine the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus spp. (VRE), extended-spectrum beta-lactamase producing organisms (ESBLs), and carbapenem-resistant Enterobacteriaceae (CRE) among residents and in the environment of nursing homes (NHs).

DESIGN:

Point prevalence sampling of residents and environmental sampling of high-touch objects in resident rooms and common areas.

SETTING:

Twenty-eight NHs in Southern California from 2016 to 2017.

PARTICIPANTS:

NH participants in Project PROTECT, a cluster-randomized trial of enhanced bathing and decolonization vs routine care.

METHODS:

Fifty residents were randomly sampled per NH. Twenty objects were sampled, including 5 common room objects plus 5 objects in each of 3 rooms (ambulatory, total care, and dementia care residents).

RESULTS:

A total of 2797 swabs were obtained from 1400 residents in 28 NHs. Median prevalence of multidrug-resistant organism (MDRO) carriage per NH was 50% (range 24%-70%). Median prevalence of specific MDROs were as follows MRSA, 36% (range 20%-54%); ESBL, 16% (range 2%-34%); VRE, 5% (range 0%-30%); and CRE, 0% (range 0%-8%). A median of 45% of residents (range 24%-67%) harbored an MDRO without a known MDRO history. Environmental MDRO contamination was found in 74% of resident rooms and 93% of common areas. CONCLUSIONS AND IMPLICATIONS In more than half of the NHs, more than 50% of residents were colonized with MDROs of clinical and public health significance, most commonly MRSA and ESBL. Additionally, the vast majority of resident rooms and common areas were MDRO contaminated. The unknown submerged portion of the iceberg of MDRO carriers in NHs may warrant changes to infection prevention and control practices, particularly high-fidelity adoption of universal strategies such as hand hygiene, environmental cleaning, and decolonization.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cross Infection / Methicillin-Resistant Staphylococcus aureus / Vancomycin-Resistant Enterococci Type of study: Clinical_trials / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Am Med Dir Assoc Journal subject: HISTORIA DA MEDICINA / MEDICINA Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cross Infection / Methicillin-Resistant Staphylococcus aureus / Vancomycin-Resistant Enterococci Type of study: Clinical_trials / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Am Med Dir Assoc Journal subject: HISTORIA DA MEDICINA / MEDICINA Year: 2020 Document type: Article
...